(Date:5/24/2013)... 2013 ResortQuest Real Estate® is proud ... Feher team at the firm’s Bethany Beach location. , ... her home in 1975. Her real estate career began ... aspects of the real estate business - receptionist, cleaning ... years, a licensed sales associate. , “I am ...
(Date:5/24/2013)... New research suggests a link between sleep duration ... Every additional hour someone with insomnia sleeps is ... likelihood of moderate or high risk of suicide, ... "We were surprised by the strength ... risk," study author, Linden Oliver, clinical research coordinator ...
(Date:5/24/2013)... used to treat glaucoma may cause droopy eyelids and ... to a new study. The drugs, known as ... pressure, have already been shown to cause blurred vision, ... suggesting that the new findings could lead to labeling ... when prescribing these drugs, the researchers added, particularly as ...
(Date:5/24/2013)... CA (PRWEB) May 24, 2013 Area homeowners ... selection of new hot tubs to choose from at factory-direct ... Sale . The sales event takes place at Emerald ... 26, 2013. , Jacuzzi, the industry's leading hot tub ... traveling across the country. The event will feature popular hot ...
(Date:5/24/2013)... mutations central to the development of infantile myofibromatosis (IM)a ... and soft tissuemay provide new therapeutic targets, according to ... Sinai. The findings, published in the American Journal ... options for this debilitating disease, for which the only ... tumors. , IM is an inheritied disorder that develops ...
Breaking Medicine News(10 mins):Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2... Del., Nov. 2 Staff and board,members of Delaware ... Lloyd, MSN, RN, for 20 years of service at ... has guided Delaware Hospice from a fledgling,grassroots organization to ... community support with quality and compassion., In 1987, ...
... Barr,Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed ... challenge of the patents listed by,Novartis Pharmaceuticals Corporation ... capsules, 10mg, 20mg, 30mg,and 40mg. Barr filed ... IV certification for a generic Ritalin LA product ...
... SOUTH PORTLAND, Maine, Nov. 2 Small employers ... much larger businesses. Anthem,Blue Cross and Blue Shield ... for small businesses (50 or fewer employees) under ... health insurance,choices than have ever been available for ...
... Urology; Initiated for ... Dermatology and OB/GYN, ... force in measuring the impact of pharmaceutical promotion on,physicians, prescribing ... networks in alignment with emerging market,trends and rising client demand. ...
... Mass., Nov. 2 Pressure,BioSciences, Inc. (Nasdaq: PBIO ... President, and CEO, will present a corporate,overview at The ... New York City on Monday, November 5, 2007 at ... The New York Palace Hotel, New York,City. The Company,s ...
... PXS; Nasdaq: PXSL) today announced moves to expand its ... construction of a new,state of the art facility at ... the fourth quarter of 2008,Pharmaxis may lease the 7,000 ... 15 years with two options to renew of five ...
Cached Medicine News:Health News:Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN 2Health News:Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN 3Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 2Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 3Health News:Anthem Introduces New Insurance Options for Small Business 2Health News:ImpactRx Announces Expansion and Addition of Physician Information Networks 2Health News:ImpactRx Announces Expansion and Addition of Physician Information Networks 3Health News:Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th 2Health News:Pharmaxis to Expand Manufacturing Capacity 2(Date:5/24/2013)... /PRNewswire-iReach/ -- Phoenix Houses of California ... is hosting its tenth annual "Triumph For Teens" Awards ... 2013. More than 300 people are expected to attend ... treatment centers, family therapy, and prevention programs of Phoenix ... positive influences on the health and welfare of our community ...
(Date:5/24/2013)... , May 24, 2013 Heska Corporation (NASDAQ: HSKA, "Heska" ... specialty products, announced today that Dr. Robert Grieve ... Jason Napolitano , executive vice president and ... MicroCap Conference, which is being held May 30, 2013 in ... Hyatt Hotel. The Company,s presentation is scheduled ...
(Date:5/24/2013)... 24, 2013 In accordance with Rule 17.1 and ... of the United States Exchange Act, Echo Pharma Acquisition Limited ... Elan Corporation (NYSE: ELN). Background On ... an offer for the entire of the issued and to ... "Original Offer"). On 20 May 2013, Royalty ...
Breaking Medicine Technology:Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9... 27, 2007 - Gentium S.p.A. (Nasdaq:,GENT) announced ... that support the safety, activity, synergy and ... with anticancer,therapy in multiple myeloma. Investigators presented ... I/II clinical trial for patients,with refractory or ...
... WIRE)--Jun 28, 2007 - Accentia,Biopharmaceuticals, Inc. (NASDAQ: ... Jefferies Healthcare Conference that its interim,analysis of ... patients in the,Fast-Tracked Phase 3 clinical study ... substantial improvement in,resolution of one or both ...
Cached Medicine Technology:Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3Accentia Biopharmaceuticals Announces Favorable Interim Blinded,Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial,for Chronic Sinusitis 2Accentia Biopharmaceuticals Announces Favorable Interim Blinded,Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial,for Chronic Sinusitis 3Accentia Biopharmaceuticals Announces Favorable Interim Blinded,Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial,for Chronic Sinusitis 4The 5524-7.5 linear transducer is a high frequency transducer dedicated to superficial and vascular imaging....
The 5539-7.5 linear transducer is a high frequency transducer dedicated to superficial and vascular imaging....
HST, versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
Scan internal organs percutaneously while eliminating side lobe artifact....
Medicine Products:Biology NavigationMedical Navigation